Alterations of Coagulation and Fibrinolysis System in Lung Cancer
폐암 환자에서 혈액 응고 및 섬유소 용해계의 이상
김, 형중; 김, 은숙; 안, 철민; 김, 성규; 이, 원영; 송, 경순; 박, 광주
The Korean journal of medicine, 54(4):467-472, 1998
The Korean journal of medicine; 대한내과학회지
Objectives : It is well known that malignant diseases exhibit an increased propensity
to clotting and fibrinolytic aberrations and early detection of these hemostatic alterations is very important for the rapid institution of appropriate treatment of thromboembolic and hemorrhagic complications in patients with malignant disease. The incidence of these abnormalities in lung cancer was reported from 20% up to 95% according to various investigators using different hemostatic parameters. We measured the concentrations of plasma thrombinantithrombin Ⅲ complex(TAT) and plasmin-α 2-plasmin inhibitor complex(PIC), which are newly developed sensitive
molecular markers of coagulation and fibrinolysis system respectively in patients with lung cancer and determined the degree of these hemostatic abnormalities according to the histologic types and different clinical stages in patients with lung cancer.
Methods : We measured the concentrations of plasma TAT and PIC in 62 patients
with histologically confirmed lung cancer, and we determined stage radiologically in
nonsurgical patients and pathologically in surgical patients. The plasma TAT and PIC
levels were assayed using a solid phase enzyme immunoassay with Enzygnost-TAT
kit(Behringwerke, Marburg, Germany) and Enzygnost-PAP kit(Behringwerke, Marburg,
Results : The concentrations of plasma TAT(6.8±4.8ng/mL) and PIC(644.3±330.5
ng/mL) in Patients with lung cancer were significantly increased compared to those of
plasma TAT(2.8± 1.2 ng/mL) and PIC(240.4±69.7 ng/mL) in control subjects(p0.05).
Conclusions : There was a subclinical activation of coagulation and fibrinolysis system in patients with lung cancer although they don't have overt clinical evidences of
thromboembolism or hemorrhage. But there were no different activation of coagulation
and fiblinolysis system according to histologic types and clinical stages.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Total Visit :2,930,968
Total Download :1,184,765
Today View :1,066
Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312 / FAX : 031-219-5314 Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved. AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.